Schrodinger is trading at $19.77, down -5.16%, primarily amid weakness across software stocks.
- Broader U.S. indexes traded higher on September 2, 2026, while software stocks fell approximately 3% during regular trading.
- No clear company-specific catalyst has been disclosed; the September 2 announcement only confirmed participation in Morgan Stanley’s September 14 healthcare conference.
- Recent earnings and collaboration news are older and do not directly explain today’s decline.